Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
03/2013
03/21/2013US20130072463 Pharmaceutical compositions useful for preventing and treating cancer
03/21/2013US20130072461 Triazole compounds that modulate hsp90 activity
03/21/2013US20130072460 Methods Of Treating Retroviral Infections And Related Dosage Regimes
03/21/2013US20130072459 Pharmaceutical composition for the prevention or the treatment of non-alcoholic fatty liver disease and the method for prevention or treatment of non-alcoholic fatty liver disease using the same
03/21/2013US20130072458 Methods of Treating Viral Associated Diseases
03/21/2013US20130072457 Pyrazolyl quinazoline kinase inhibitors
03/21/2013US20130072456 Bicyclic tetrahydropyrrole compounds
03/21/2013US20130072455 Methods and Compositions for Treating Ectoparasite Infestation
03/21/2013US20130072454 Anti-diabetic compostions and methods
03/21/2013US20130072453 Heat stable hyaluronic acid compositions for dermatological use
03/21/2013US20130072452 Pharmaceutical composition and method for inhibiting inflammation
03/21/2013US20130072450 Antioxidative and hepatoprotective compositions containing diarylheptanoids from alnus japonica
03/21/2013US20130072449 Lysophosphatidic acid receptor antagonists
03/21/2013US20130072448 Drug Combination Comprising A Glycolysis Inhibitor And A Tyrosine Kinase Inhibitor
03/21/2013US20130072443 Stabilized mutant opsin proteins
03/21/2013US20130072428 Methods and Compounds Regulating the Erythroid Response to Iron Deficiency
03/21/2013US20130072427 Gpr 119 modulators
03/21/2013US20130072426 Diagnostic methods for obesity and related disorders
03/21/2013US20130072421 Treatment of sirtuin (sirt) related diseases by inhibition of natural antisense transcript to a sirtuin (sirt)
03/21/2013US20130071496 Controlled release composition containing a strontium salt
03/21/2013US20130071495 Inhibitors of glycogen synthase kinase 3 for use in therapeutic methods and screening method relating thereto
03/21/2013US20130071490 X-ray contrast media compositions and methods of using the same to treat, reduce or delay the onset of cns inflammation and inflammation associated conditions
03/21/2013US20130071489 Methods and compositions for safe and effective treatment of erythema
03/21/2013US20130071482 Block copolymer cross-linked nanoassemblies as modular delivery vehicles
03/21/2013US20130071477 New abuse-resistant pharmaceutical composition for the treatment of opioid dependence
03/21/2013US20130071476 Rapid Melt Controlled Release Taste-Masked Compositions
03/21/2013US20130071475 Method For Producing An Oral Pharmaceutical Form With Immediate Disintegration And Active Ingredient Release
03/21/2013US20130071474 COMBINATIONS OF BERBERINE, ARTEMISININ, Loperamide AND THEIR DERIVATIVES TO TREAT MALARIA, DIARRHEA, TRAVELERS' DIARRHEA, DYSENTERY, DENGUE FEVER, PARASITES, CHOLERA AND VIRUSES
03/21/2013US20130071472 Fascile synthesis of biocompatible polymer capsule nanoparticles for drug encapsulation
03/21/2013US20130071471 Pharmaceutical composition for treating atopic dermatitis
03/21/2013US20130071469 Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
03/21/2013US20130071468 Lipid-Based Compositions of Antiinfectives for Treating Pulmonary Infections and Methods of Use Thereof
03/21/2013US20130071467 Retinoid-liposomes for treating fibrosis
03/21/2013US20130071464 Composition comprising phosphonic acid polymer for use as tissue engineering fibrous scaffold
03/21/2013US20130071458 Active agents and their oligomers and polymers
03/21/2013US20130071452 Pharmaceutical composition comprising amide derivative or pharmaceutically acceptable salt thereof
03/21/2013US20130071448 Treatment of t-cell mediated diseases
03/21/2013US20130071446 Infant nutrition for improving fatty acid composition of brain membranes
03/21/2013US20130071445 Transluminal drug delivery methods and devices
03/21/2013US20130071443 Glycosaminoglycans
03/21/2013US20130071442 Aerosolized Fosfomycin/Aminoglycoside Combination for the Treatment of Bacterial Respiratory Infections
03/21/2013US20130071440 Use of simple amino acids to form porous particles
03/21/2013US20130071439 Methods and compositions for treating biofilms
03/21/2013US20130071438 Compositions and methods for the treatment of hyperplasia
03/21/2013US20130071436 Treatment of t-cell mediated diseases
03/21/2013US20130071426 Topical pharmaceutical or cosmetic composition useful for the treatment of diseases or conditions that transcur through a deficit of maturation of the cornified envelope
03/21/2013US20130071421 Turkey viral hepatitis virus and uses thereof
03/21/2013US20130071419 Universal dengue virus sequences and methods of use
03/21/2013US20130071408 Methods for Diagnosis and Treatment of Non-Insulin Dependent Diabetes Mellitus
03/21/2013US20130071407 Methods for modulating hematopoiesis and vascular growth
03/21/2013US20130071402 Pharmacogenetic test anti-resorptive therapy-associated osteonecrosis of the jaw
03/21/2013US20130071382 Egfr mutations
03/21/2013US20130071372 Metallo-protein and tocotrienol (mp-t3) compositions with non-protein-type metal chelator and uses thereof
03/21/2013US20130071369 Oral Formulations For Promoting Cellular Purification
03/21/2013US20130071368 Preparation, use of preparation for treatment, and method of treatment of intestinal infection
03/21/2013US20130071354 Modulators of toll-like receptors
03/21/2013US20130071353 Antiviral Compounds and Methods of Use Thereof
03/21/2013US20130071352 5,5-fused arylene or heteroarylene hepatitis c virus inhibitors
03/21/2013US20130071350 Method and compositions for treatment of cancers
03/21/2013US20130071349 Biodegradable polymers for lowering intraocular pressure
03/21/2013US20130071342 Cosmetic composition comprising coumestrol or a bean extract containing coumestrol for skin care
03/21/2013US20130071338 Formulation comprising nicotine and a cation exchange resin
03/21/2013US20130071337 Interomone Compositions and Their Use to Modify Behavior in Different Vertebrate Species
03/21/2013US20130071336 Injectable Cross-Linked Polymeric Preparations and Uses Thereof
03/21/2013US20130071323 Therapies for hematologic malignancies
03/21/2013US20130071321 Delivery of agents to inflamed tissues using folate-targeted liposomes
03/21/2013US20130071320 Immunotherapy of autoimmune disorders using antibodies which target b-cells
03/21/2013US20130068218 Process for producing metered dose inhaler formulations
03/21/2013DE69627384C5 Antiparasitäre zusammensetzung zur behandlung und zum schutz von haustieren Antiparasitic composition for the treatment and protection of house pets
03/21/2013DE202012011888U1 Kristallines Mehrkomponentensystem von Rosuvastatin-Calciumsalz und Vanillin Crystalline multicomponent system of rosuvastatin calcium salt and vanillin
03/21/2013DE102012018052A1 Pharmazeutisches Kombinationspräparat The pharmaceutical combination product
03/21/2013DE102011113652A1 Kristallisierung von Idarubicinhydrochlorid Crystallization of idarubicin hydrochloride
03/21/2013CA2852989A1 Compositions for treating bone diseases and broken bones
03/21/2013CA2848979A1 Plant steroids and uses thereof
03/21/2013CA2848877A1 Use of indolyl and indolinyl hydroxamates for treating heart failure of neuronal injury
03/21/2013CA2848809A1 6-substituted 3-(quinolin-6-ylthio)-[1,2,4]triazolo[4,3-a]pyradines as c-met tyrosine kinase
03/21/2013CA2848806A1 Sulfonic acid salts of heterocyclylamide-substituted imidazoles
03/21/2013CA2848786A1 Ep1 receptor ligands
03/21/2013CA2848764A1 Controlled dosing of clopidogrel with gastric acid inhibition therapies
03/21/2013CA2848756A1 Phased dosing of clopidogrel
03/21/2013CA2848724A1 Phosphatidylinositol 3-kinase inhibitors for the treatment of cancer
03/21/2013CA2848659A1 Indazole-3-carboxamides and their use as wnt/b-catenin signaling pathway inhibitors
03/21/2013CA2848621A1 Synthesis of triazolopyrimidine compounds
03/21/2013CA2848616A1 Disubstituted 5-fluoro-pyrimidines
03/21/2013CA2848615A1 Disubstituted 5-fluoro pyrimidine derivatives containing a sulfoximine group
03/21/2013CA2848567A1 Products for healing of tissue wounds
03/21/2013CA2848561A1 Guanidinobenzoic acid compound
03/21/2013CA2848557A1 Tetrahydrotriazolopyrimidine derivatives as human neutrophil elastase inhibitors
03/21/2013CA2848540A1 Therapeutic compounds
03/21/2013CA2848506A1 Certain chemical entities, compositions, and methods
03/21/2013CA2848493A1 Formulations of cyclopropanecarboxylic acid {2-[(1s)-1-(3-ethoxy-4-methoxy-phenyl)-2-methanesulfonyl-ethyl]-3-oxo-2,3-dihydro-1h-isoindol-4-yl}-amide
03/21/2013CA2848453A1 Combination therapy using ribavirin as eif4e inhibitor
03/21/2013CA2848410A1 Rna engineered t cells for the treatment of cancer
03/21/2013CA2848382A1 Method for enhancing crop yields by application of trehalose
03/21/2013CA2848317A1 Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
03/21/2013CA2848231A1 New use of melatonine
03/21/2013CA2848226A1 Plant growth regulating compounds
03/21/2013CA2848219A1 Compositions of jasmonate compounds and methods of use
03/21/2013CA2848210A1 Use of 4-amino-5-fluoro-3-[6-(4-methylpiperazin-1-yl)-1h-benzimidazol-2-yl]-1h-quinolin-2-one in the treatment of cancer in moderate hepatic impaired patients
03/21/2013CA2848156A1 Ophthalmic compositions comprising prostaglandin f2 alpha derivatives and hyaluronic acid
1 ... 790 791 792 793 794 795 796 797 798 799 800 801 802 803 804 805 806 807 808 809 810 ... 7860